T5 Oral dietary nitrate supplementation to enhance pulmonary rehabilitation in chronic obstructive pulmonary disease: a multi-centre, double blind, placebo-controlled, parallel group study

Pulmonary Disease ◽

Pulmonary Rehabilitation ◽

Chronic Obstructive ◽

Double Blind ◽

Dietary Nitrate ◽

Double Blind Placebo ◽

Parallel Group ◽

Nitrate Supplementation

Supplemental dietary nitrate for chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled, crossover trial

Proceedings of The Nutrition Society ◽

10.1017/s0029665113001705 ◽

2013 ◽

Vol 72 (OCE3) ◽

Cited By ~ 1

Author(s):

C. P. Kerley ◽

K. Cahill ◽

K. Bolger ◽

K. Fennell ◽

A. O'Brien ◽

...

Keyword(s):

Pulmonary Disease ◽

Crossover Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Dietary Nitrate ◽

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.201901-0048le ◽

2019 ◽

Vol 200 (5) ◽

pp. 642-645 ◽

Cited By ~ 1

Author(s):

Jaclyn A. Smith ◽

Lorcan McGarvey ◽

Alyn H. Morice ◽

Surinder S. Birring ◽

Jadwiga A. Wedzicha ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group

A double blind randomized placebo control crossover trial on the effect of dietary nitrate supplementation on exercise tolerance in stable moderate chronic obstructive pulmonary disease

BMC Pulmonary Medicine ◽

10.1186/s12890-015-0057-4 ◽

2015 ◽

Vol 15 (1) ◽

Cited By ~ 22

Author(s):

Paul Leong ◽

Jane E Basham ◽

Theresa Yong ◽

Adrian Chazan ◽

Paul Finlay ◽

...

Keyword(s):

Pulmonary Disease ◽

Exercise Tolerance ◽

Crossover Trial ◽

Placebo Control ◽

Chronic Obstructive ◽

Double Blind ◽

Dietary Nitrate ◽

Nitrate Supplementation

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease

Respiratory Research ◽

10.1186/s12931-017-0647-1 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 16

Author(s):

Krishna K. Pudi ◽

Chris N. Barnes ◽

Edmund J. Moran ◽

Brett Haumann ◽

Edward Kerwin

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Faculty Opinions recommendation of Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718348198.793494105 ◽

2014 ◽

Author(s):

Adam Wanner ◽

Timothy Scialla

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Parallel Group

Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30057-7 ◽

2016 ◽

Vol 36 (4) ◽

pp. 418-426 ◽

Cited By ~ 1

Author(s):

Liu Miao ◽

Zheng Fengjie ◽

Ni Lei ◽

Sun Yan ◽

Wu Ruohan ◽

...

Keyword(s):

Adjuvant Therapy ◽

Dietary Fiber ◽

Pulmonary Disease ◽

Sugarcane Bagasse ◽

Controlled Study ◽

Chronic Obstructive ◽

Double Blind ◽

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Cited By ~ 51

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Mapk Inhibitor

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70286-8 ◽

2014 ◽

Vol 2 (3) ◽

pp. 187-194 ◽

Cited By ~ 110

Author(s):

Jin-Ping Zheng ◽

Fu-Qiang Wen ◽

Chun-Xue Bai ◽

Huan-Ying Wan ◽

Jian Kang ◽

...

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

MON-P145: The Effect of Dietary Nitrate Supplementation on Mechanical Efficiency and Cardiometabolic Risk Profile in Patients with Chronic Obstructive Pulmonary Disease

Clinical Nutrition ◽

10.1016/s0261-5614(17)30941-x ◽

2017 ◽

Vol 36 ◽

pp. S232

Author(s):

R.J.H.C.G. Beijers ◽

S. Huysmans ◽

C. van de Bool ◽

B.R.M. Kingma ◽

L.B. Verdijk ◽

...

Keyword(s):

Pulmonary Disease ◽

Cardiometabolic Risk ◽

Mechanical Efficiency ◽

Risk Profile ◽

Chronic Obstructive ◽

Dietary Nitrate ◽

Nitrate Supplementation